The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
Subscribe To Our Newsletter & Stay Updated
